World Conference on Lung Cancer 2019

Share on: 
September 7 to September 10, 2019
Fira de Barcelona - Gran Via

Research coauthored by RTI Health Solutions researchers will be presented at the 2019 World Conference on Lung Cancer.

Genetic testing patterns, treatment characteristics, and overall survival in ALK-positive metastatic NSCLC patients treated with Ceritinib.
Mazieres J, Ahn MJ, Chouaid C, Kron A, Wolf J, Goyal RK, Davis KL, Perrinjaquet M, Pham T, Knoll S. 




Related Services:
Conference participants: